22nd Century Group (XXII) Shares Down 5.4%

22nd Century Group Inc (NYSEAMERICAN:XXII)’s share price dropped 5.4% during mid-day trading on Thursday . The stock traded as low as $2.61 and last traded at $2.62. Approximately 1,557,853 shares traded hands during trading, an increase of 22% from the average daily volume of 1,272,650 shares. The stock had previously closed at $2.77.

Separately, TheStreet raised 22nd Century Group from a “d” rating to a “c-” rating in a report on Monday, November 26th.

22nd Century Group (NYSEAMERICAN:XXII) last posted its quarterly earnings data on Wednesday, November 7th. The biotechnology company reported $0.04 earnings per share (EPS) for the quarter. The firm had revenue of $6.26 million for the quarter.

A number of large investors have recently bought and sold shares of the business. Metropolitan Life Insurance Co. NY bought a new stake in shares of 22nd Century Group during the 2nd quarter valued at $102,000. Voya Investment Management LLC bought a new stake in shares of 22nd Century Group during the 2nd quarter valued at $106,000. MetLife Investment Advisors LLC bought a new stake in shares of 22nd Century Group during the 2nd quarter valued at $145,000. Bank of Nova Scotia bought a new stake in shares of 22nd Century Group during the 2nd quarter valued at $158,000. Finally, Dimensional Fund Advisors LP bought a new stake in shares of 22nd Century Group during the 3rd quarter valued at $227,000.

COPYRIGHT VIOLATION NOTICE: “22nd Century Group (XXII) Shares Down 5.4%” was reported by PressOracle and is the sole property of of PressOracle. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The correct version of this story can be read at https://pressoracle.com/news/2019/01/11/22nd-century-group-xxii-shares-down-5-4.html.

About 22nd Century Group (NYSEAMERICAN:XXII)

22nd Century Group, Inc, a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies.

Featured Article: What does the Dow Jones Industrial Average (DJIA) measure?

Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Leave a Reply